Repare Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RPTX and other ETFs, options, and stocks.About RPTX
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
CEOSteve Forte
CEOSteve Forte
Employees129
Employees129
HeadquartersSaint-Laurent, Québec
HeadquartersSaint-Laurent, Québec
Founded2016
Founded2016
Employees129
Employees129
RPTX Key Statistics
Market cap93.33M
Market cap93.33M
Price-Earnings ratio-1.27
Price-Earnings ratio-1.27
Dividend yield—
Dividend yield—
Average volume604.81K
Average volume604.81K
High today$2.20
High today$2.20
Low today$2.15
Low today$2.15
Open price$2.18
Open price$2.18
Volume250.02K
Volume250.02K
52 Week high$2.30
52 Week high$2.30
52 Week low$0.89
52 Week low$0.89
Stock Snapshot
The current Repare Therapeutics(RPTX) stock price is $2.18, with a market capitalization of 93.33M. The stock trades at a price-to-earnings (P/E) ratio of -1.27.
On 2025-12-18, Repare Therapeutics(RPTX) stock moved within a range of $2.15 to $2.20. With shares now at $2.18, the stock is trading +1.4% above its intraday low and -0.9% below the session's peak.
Trading volume for Repare Therapeutics(RPTX) stock has reached 250.02K, versus its average volume of 604.81K.
Over the past 52 weeks, Repare Therapeutics(RPTX) stock has traded between a high of $2.30 and a low of $0.89.
Over the past 52 weeks, Repare Therapeutics(RPTX) stock has traded between a high of $2.30 and a low of $0.89.
People also own
Based on the portfolios of people who own RPTX. This list is generated using Robinhood data, and it’s not a recommendation.